MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates
June 21, 2021 07:00 ET
|
MediPharm Labs Corp.
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple...
Pamrevlumab Included in Pancreatic Cancer Action Network’s Adaptive Clinical Trial Platform
June 16, 2021 08:00 ET
|
FibroGen, Inc
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced activation of an experimental arm in the Pancreatic Cancer Action Network's (PanCAN) Precision PromiseSM...
Sorrento Receives Authorization From the UK Regulatory Agency to Conduct a Phase 2 Clinical Trial for COVI-DROPS in an Outpatient Setting
June 11, 2021 16:11 ET
|
Sorrento Therapeutics, Inc.
Large Phase 2 efficacy trial cleared to start in the United Kingdom in newly diagnosed SARS-CoV-2 infected patients.COVI-DROPS is administered by intranasal drops and the antibody is active against...
Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US
June 11, 2021 07:00 ET
|
Theralase Technologies Inc.
TORONTO, June 11, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress
June 11, 2021 03:03 ET
|
Immunicum AB
Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress - Den pågående ADVANCE-II-studien, som utvärderar DCP-001 hos...
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
June 11, 2021 03:03 ET
|
Immunicum AB
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress -- Ongoing ADVANCE II study evaluating DCP-001 in AML patients is nearing...
Axiom Presents "Benefits and Advantages of a Unified Platform Approach to Global Studies" at BIO Digital 2021
June 10, 2021 09:10 ET
|
Axiom Real-Time Metrics Inc
TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
Results from Qu Biologics’ Crohn’s Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021
June 09, 2021 09:00 ET
|
Qu Biologics, Inc.
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
June 03, 2021 14:40 ET
|
Royal Philips
June 3, 2021 Results show that first-of-its-kind device has a sustained treatment effect and a positive impact on quality of life Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,...
Avricore Health Signs Master Agreement to Pilot HealthTab™ Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies
June 03, 2021 09:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have...